35 results about "Therapy Outcome" patented technology

Systems and methods for steering one or more stimulation fields to a selected nerve target, thereby optimizing one or a combination of low stimulation thresholds, desired therapy outcomes, or a minimization of adverse stimulation side-effects. An array of electrodes disposed, at least in part, on two or more neural stimulation leads are used for steering the stimulation fields to the selected nerve target and are positioned adjacent the selected target. The stimulation may be titrated based on, among other things, a detected physiologic response to the applied stimulation.

In one illustrative embodiment, a tele-rehabilitation platform allows patients to play and interact with therapists, caregivers, and other patients. The platform includes a set of computer games, a therapist portal, and a knowledgebase for the storage and analysis of therapy outcomes for specific patients, conditions, and therapy regimes.

A system for fully automating the administration of a health plan. The system accepts inputs from enrollees, insureds, providers, insurers and vendors, but requires no physical data entry from the plan administrator. The system also features an automated methodology that measures patient treatment outcomes in terms of quality-adjusted life-years, by diagnosis and by medical treatment provider. The system also includes automated methods for: a “just-in-time” appointment scheduler, an editable archive of prototypical treatment plans, measuring the diagnostic accuracy of diagnostic physicians and for measuring the complication rate of treatment providers.

A method of evaluating a cancer patient comprising evaluating gene expression levels in a patient sample, calculating a predictor score using the gene expression levels, and assessing the likelihood of a therapeutic outcome using the predictor score is disclosed.

The invention provides a method for determining the outcome of treatment with an antidepressant medication in a patient. In particular, the invention provides a method of screening patients to identify those patients with a decreased risk of non-response to treatment with antidepressant medication by obtaining a sample of genetic material from the patients, and then assaying the sample for the presence of a genotype which is associated with a decreased risk of non-response to treatment with antidepressant medication. The genotype is characterized by a polymorphism in the genes HTR2A, GRIK4, BCL2, and a combination thereof.

The present invention provides a method for selecting a specific population of women at risk of developing an obstetric or gynecological condition, the risk being expressed by an odds ratio (OR) value higher than 5.5, the method comprising the following steps in sequence: a) passing Determination of sialidase levels in body fluid samples by the method described by Cauci et al. in Am. J. Obstet. Gynecol. 1998; vol. 178; p511-5, and / or, by Cauci et al. in J. Infect. Dis.1998; vol.178; method described in p1698-706, to determine the activity of aminoacyl proline dipeptidase in a body fluid sample; b) determine the pH value of the body fluid sample; c) select a value with sialidase Samples with equal or higher than 5.0 nmol methoxyphenol and / or aminoacyl proline dipeptidase levels equal to or higher than 1500 mOD and pH ≥ 5.0. Thus, this approach provides physicians with an effective tool in deciding whether to administer drug therapy to women at risk of serious adverse outcomes.

The invention discloses a chronic insomnia (CI) remote cognitive-behavioural therapy system. The system comprises at least one patient mobile terminal; the patient mobile terminal is connected with a central workstation by internet; the central workstation is connected with at least one doctor mobile terminal by the internet. The patient mobile terminal comprises a patient mobile communication platform comprising a communication module I, an inspection conclusion import module, a standard interview module, a therapeutic schedule export module and an individualized prescription module; the central workstation comprises a server and a personal computer; the server comprises an optimizing module, a communication module II and a storage module; the doctor mobile terminal comprises a communication module III, a therapeutic schedule module, a therapy monitoring module and a therapy result analysis module. The cognitive-behavioural therapy basic interview is standardized by using the internet technology, the long-distance persistent CI cognitive-behavioural therapy is realized, and more CI patients are treated under limited medical resources.

The invention discloses an intelligent feedback type music relaxation hypnotic therapy system and an implementation method. The intelligent feedback type music relaxation hypnotic therapy system comprises a state monitoring module, an automatic playing module, a language hinting module, a treatment feedback module and a display module, wherein the state monitoring module comprises heart rate monitoring, respiration monitoring, limb movement monitoring and blood pressure monitoring; the automatic playing module comprises intelligent song selecting, artificial song selecting and a pre-set playing list; the language hinting module comprises a pre-set language base, a player, background replacement and atmosphere selection; and the treatment feedback module comprises a treatment result, a treatment problem and a solution. According to the intelligent feedback type music relaxation hypnotic therapy system disclosed by the invention, through monitoring respects related to body movement and mood of a curee, the system can automatically play music to enable the curee to relax and play hinting languages to achieve the treatment effects, and the technical requirements are reduced; besides, the playing opportunity of the music and hinting languages can be mastered in place, and the problem that a traditional manner is subjected to the influence of the experience of a curer, and the effectis unstable is solved.

The present invention relates to methods for the localisation, diagnosis, prognosis and / or prediction of therapeutic outcome of cancer, as well as methods for treating or preventing cancer. In particular, the present invention relates to methods for the localisation, diagnosis, prognosis and / or prediction of therapeutic outcome of brain tumors expressing calcitonin receptor, as well as the treatment and prevention of brain tumors by targeting calcitonin receptor expressing brain tumour cells.

This invention relates generally to antigens reactive with autoantibodies associated with autoimmune sensorineural hearing loss (AISNHL), and in particular relates to a novel antigen, Inner Ear Supporting Cell Antigen (IESCA) reactive with autoantibodies associated with autoimmune sensorineural hearing loss (AISNHL), and to methods for the detecting therapeutic outcomes in treatment of AISNHL patients, and to methods of detecting genetic lesions in genes encoding for such antigens.

The proposed apparatus and method relate to restorative sports medicine and patient rehabilitation with neurological motoric disorders. A patient is positioned in equilibrium by suspension devices for patient's body parts. The suspension devices are moved by actuating mechanisms with an electro-pneumatic drive and actuating components, controlled by a programmed computer, motivating the patient by controlling an object in a virtual gaming environment, to restore movements when there is an initially minimal or a complete absence of physical activity. The effectiveness is judged according to the reduction of energy consumption of the drives. The apparatus includes a base composed of two parallel guides with movable crossbars, on which the actuating mechanisms are pairwise movably arranged, monitoring and control units, the computer, sensors detecting the state of the actuating mechanisms, and power sources. There are units for analyzing the energy consumption of each drive and for assessing the treatment results.